Abstract: The present disclosure relates to a process and apparatus for capturing carbon dioxide in flue gas, and the present disclosure performs a carbon dioxide recovery separation membrane process using cold heat in a carbon dioxide liquefaction process through a separation tower, thereby reducing energy consumption and remarkably improving separation efficiency.

Abstract: The present disclosure is broadly concerned with the field of cancer immunotherapy. For example, the present invention generally relates to an immune cell comprising a genetically engineered antigen receptor that specifically binds to a target antigen and a genetic disruption agent that reduces or is capable of reducing the expression in the immune cell of a gene that weakens the function of the immune cell.

Abstract: An embodiment electric vehicle drive apparatus for decreasing a drive speed of a motor and transferring the decreased drive speed to an output shaft is provided. The apparatus includes a first planetary gear set including three first planetary gear elements in which a first element is connected to the motor and a second element is connected to a first output shaft, a second planetary gear set including three second planetary gear elements in which a first element is connected to a third element of the three first planetary gear elements, a second element is connected to a second output shaft, and a third element is fixed, and a third planetary gear set including three third planetary gear elements in which first and second elements are connected to two elements of the three first planetary gear elements, respectively, and a third element is connected to a torque vectoring motor.

Abstract: A display device includes at least one pixel configured to receive a voltage of an initialization power source, which is supplied to an anode electrode of a light emitting element, when an enable scan signal is supplied to a scan line, and a scan driver. The scan driver is configured to supply the enable scan signal to the scan line. The enable scan signal supplied to the scan line by the scan driver has a same width during an active area of a frame regardless of an image refresh rate, and the width of the enable scan signal supplied to the scan line is changed by the scan driver during a blank area of the frame, corresponding to the image refresh rate.

Abstract: A liver-targeted drug and therapeutic use thereof for diseases requiring drug action in the liver are disclosed. A method in which a substance having activity with respect to glucagon is used so as to induce delivery of the liver-targeted drug to liver tissues or an increase in distribution of the drug in liver tissues after in vivo administration.

Abstract: A light emitting element includes: a light emitting stack pattern including a first semiconductor layer, an active layer, and a second semiconductor layer that are sequentially stacked along one direction; and an insulating film surrounding an outer surface of at least one of the first semiconductor layer, the active layer, and the second semiconductor layer. The insulating film including a zinc oxide (ZnO) thin film layer.

Abstract: The disclosure relates to a composition for labeling a target lesion, in form of microspheres including a biocompatible polymer; and a dye for biological tissue, and directly administered to a target lesion to confirm size and location of the target lesion in real time during surgery at a target site and a method preparing the same. The composition for labeling a target lesion of the present disclosure, when injected into a target lesion, remains there for several months and can detect the location and size of the labeled lesion in real time during surgery, thereby not only improving the success rate of surgical operation for the target lesion, but also preventing excessive loss of normal tissue, and therefore can be widely utilized as an effective surgical marker.

Abstract: The present disclosure relates to an apparatus for managing a wound and a method of operating an apparatus for managing a wound. The method includes acquiring a measured image including a color chart, acquiring a location of a first marker included in the color chart based on the measured image, acquiring a location of a second marker included in the color chart based on the measured image, acquiring a location of a third marker included in the color chart based on the measured image, acquiring a location of a fourth marker included in the color chart based on the measured image, and acquiring center points of a plurality of color patches included in the color chart based on the location of the first marker, the location of the second marker, the location of the third marker, and the location of the fourth marker.

Abstract: The present invention relates to a compound represented by chemical formula I, a stereoisomer thereof, a pharmaceutically acceptable salt thereof, a hydrate or solvate thereof, and a pharmaceutical composition comprising same.

Abstract: Provided are a positive active material for a lithium secondary battery, a positive electrode including the same, and a lithium secondary battery including the same, the positive active material for lithium secondary batteries including a first metal oxide, which includes nickel, cobalt and manganese, being in single particle form; and a second metal oxide that contains nickel, cobalt, and manganese and is in the form of a secondary particle containing a plurality of primary particles and has an average particle diameter D50 larger than that of the first metal oxide; wherein, a nickel content of the second metal oxide is 0.8 mol or more, based on 1 mole of the total of nickel, cobalt and manganese in the second metal oxide, and a nickel content of the first metal oxide is 0.03 mole to 0.17 mole more than the nickel content of the second metal oxide.

Abstract: The present invention relates to a pharmaceutical composition comprising a microRNA (miRNA) inhibitor as an active ingredient for the prevention or treatment of a vascular smooth muscle cell proliferative disease; a kit comprising a miRNA-detectable agent for the diagnosis of a vascular smooth muscle cell proliferative disease; a method for providing information for the diagnosis of the diseases; and a therapeutic method. Discovered in the present invention were the miRNA subsets miR-132-3p, miR-370-3p, miR-130b-5p, and miR-410-3p that are involved in proliferative diseases of smooth muscle cells. It was found that these miRNAs significantly increased their expression 5-fold or more in damaged arteries, compared to the control, and in particular, miR-370-3p was highly expressed in coronary tissues of atherosclerosis patients. Thus, the miRNAs can be advantageously used for diagnosing diseases related thereto and further can find applications in treating vascular smooth muscle cell proliferative diseases.

Abstract: The present invention provides an epidermal penetration type ink composition comprising: a fluorescent colorant containing at least one selected from the group consisting of indocyanine green (ICG), cyanine, phthalocyanine, oxazine, rhodamine, and a mixture thereof; a binder resin containing at least one of polyvinylpyrrolidone (PVP) and polyvinylbutyral (PVB); and a solvent containing at least one of ethanol and isopropanol.

Abstract: A photoelectric conversion device according to some example embodiments includes an upper electrode, a lower electrode, and an active layer including a donor material, an acceptor material, and a light-absorbing material and disposed between the upper electrode and the lower electrode, wherein the donor material includes a compound represented by Formula 1, and the light-absorbing material includes bis-(4-dimethylaminodithiobenzyl)-Ni(II) (BDN).

Abstract: It is related to a positive electrode active material for lithium secondary battery, comprising: a compound represented by Chemical Formula 1, wherein a molar content of lithium present in the structure of the positive electrode active material, measured through neutron diffraction analysis, is 1.01 to 1.15 for 1 mole of the positive electrode active material, a method of preparing it, and a lithium secondary battery including the same. Li1+a(NibM11-b)1-aO2??[Chemical Formula 1] In the Chemical Formula 1, 0<a<0.2, 0.8<b<1, M1 is at least one element selected from Co, Mn, Al, Mg, Ca, Ti, V, Cr, Zr, Nb, Mo, and W.

Abstract: The present exemplary embodiments relate to a positive electrode active material and a lithium secondary battery including the same. According to an exemplary embodiment, a positive electrode active material for a lithium secondary battery including a metal oxide particle including nickel, cobalt, manganese and aluminum, and three types of doping elements doped on the metal oxide particle is provided.

Abstract: In a high pressure gas charging system and method, the system includes a charging container, a fluid supply part and a high pressure charging part. A high pressure gas is charged in the charging container. The fluid supply part is connected to a first side of the charging container, and is configured to supply incompressible fluid into the charging container before charging the high pressure gas. The high pressure charging part is connected to a second side of the charging container, and is configured to charge the high pressure gas into the charging container in which the incompressible fluid is already supplied. The incompressible fluid is supplied to the charging container until an inner pressure of the charging container reaches a predetermined pressure, and the incompressible fluid is removed to outside through the fluid supply part as the high pressure gas is charged into the charging container.

Abstract: The present invention provides a positive electrode active material, its manufacturing method and a lithium secondary battery containing the same. The positive electrode active material for a lithium secondary battery of the present invention is a positive electrode active material for lithium secondary battery, comprising: a lithium metal oxide particle; and a coating layer positioned on at least part of the lithium metal oxide particle surface; wherein, the coating layer includes any one or more of group 5 elements and group 6 elements, B, LiOH, Li2CO3 and Li2SO4.

Abstract: A positive active material, a manufacturing method thereof, and a lithium secondary battery including the same are disclosed, and a positive active material including lithium metal oxide particles in a secondary particle form including primary particles, wherein the secondary particle surface includes planar primary particles with a narrow angle of 70 to 90° from among angles between a c axis of the primary particles and a straight line connecting a virtual point of a center of the primary particle and a center point of the secondary particle may be provided.

Abstract: It is related to a positive active material for lithium secondary battery, a manufacturing method thereof, and a lithium secondary battery containing the same, provides that a positive active material for lithium secondary battery, wherein, it is a layered lithium metal compound comprises nickel, cobalt, and manganese, and aluminum, zirconium, and boron are doped.

Abstract: The present disclosure relates to a thermoplastic polyurethane composition for injection molding and a method for manufacturing the same. Specifically, the thermoplastic polyurethane composition includes 0.5% by weight to 10.0% by weight of a sulfonate diol, 13% by weight to 60% by weight of an isocyanate, 30% by weight to 70% by weight of an ether-containing polyester polyol, and 5% by weight to 40% by weight of a chain extender.